IVZ vs LNC
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 22, 2026
IVZ
68.9
AI Score
VS
IVZ Wins
LNC
66.2
AI Score
Investment Advisor Scores
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | IVZ | LNC | Winner |
|---|---|---|---|
| Revenue | 3.57B | 4.26B | LNC |
| Net Income | 558.00M | 490.00M | IVZ |
| Net Margin | 15.6% | 11.5% | IVZ |
| ROE | 4.5% | 3.3% | IVZ |
| ROA | 2.0% | 0.2% | IVZ |
| Total Assets | 27.47B | 303.85B | LNC |
Relative Price Performance (Last 90 Days)
IVZ 1M: -6.6%
· 3M: -4.1%
LNC 1M: -0.6%
· 3M: -1.3%
Current Technical Phase
IVZ
MarkdownSell / avoid
Price below a falling SMA50 (slope -1.1%), weak momentum, RSI 40
LNC
NeutralHold
Mixed signals - no dominant trend phase, RSI 49
Fundamentals Snapshot
| Metric | IVZ | LNC |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 9.0 | 4.6 |
| Trailing P/E | — | 3.4 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.2% | 0.1% |
| Gross Margin | 0.3% | 0.3% |
| Operating Margin | 0.2% | 0.0% |
| EPS | -0.68 | 11.73 |
| Dividend Yield | 0.03% | 0.05% |
Frequently Asked Questions
Based on our detailed analysis, IVZ is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.